mRNA |
tigecycline |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.002 |
mRNA |
BRD1835 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.002 |
mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
0.3 |
0.002 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.003 |
mRNA |
dexamethasone |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.003 |
mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |